{
    "Title": "Anti-leishmanial activity of Brevinin 2R and its Lauric acid conjugate type against L. major: In vitro mechanism of actions and in vivo treatment potentials",
    "URL": "https://doi.org/10.1371/journal.pntd.0007217",
    "Published": "February 27, 2019",
    "Subject_Areas": [
        "Promastigotes",
        "Parasitic diseases",
        "Membrane potential",
        "Apoptosis",
        "Leishmaniasis",
        "Mitochondria",
        "Amastigotes",
        "Cell membranes"
    ],
    "Authors": {
        "Farnaz Zahedifard": [
            "Immunotherapy and Leishmania Vaccine Research Department, Pasteur Institute of Iran, Tehran, Iran",
            "Leishmania Research Lab, Institut Pasteur Korea, Seongnam-si, Republic of Korea"
        ],
        "Hyeryon Lee": [
            "Leishmania Research Lab, Institut Pasteur Korea, Seongnam-si, Republic of Korea"
        ],
        "Joo Hwan No": [
            "Leishmania Research Lab, Institut Pasteur Korea, Seongnam-si, Republic of Korea"
        ],
        "Mona Salimi": [
            "Physiology and Pharmacology Department, Pasteur Institute of Iran, Tehran, Iran"
        ],
        "Negar Seyed": [
            "Immunotherapy and Leishmania Vaccine Research Department, Pasteur Institute of Iran, Tehran, Iran"
        ],
        "Ahmad Asoodeh": [
            "Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran"
        ],
        "Sima Rafati": [
            "Immunotherapy and Leishmania Vaccine Research Department, Pasteur Institute of Iran, Tehran, Iran"
        ]
    }
}